HARCP

HEROIN ADDICTION AND
RELATED CLINICAL PROBLEMS

The official journal of
EUROPAD - European Opiate Addiction Treatment Association
WFTOD - World Federation for the Treatment of Opioid Dependence
Editor: Icro Maremmani, MD - Pisa, Italy, EU
Associate Editors:
Thomas Clausen, MD - Oslo, Norway
Pier Paolo Pani, MD - Cagliari, Italy, EU
Marta Torrens, MD - Barcelona, Spain, EU
Statistical Editor:
Mario Miccoli, PhD - Pisa, Italy, EU

HARCP Archives

Browse by article Browse by volume    

Heroin Addiction and Related Clinical Problems: 2024, 26, 43

Clinical characterisation of dual depression and association with bipolarity features

Margherita Barbuti, Jean-Michel Azorin, Jules Angst, Charles L. Bowden, Sergey Mosolov, Allan H. Young, Eduard Vieta, Giulio Perugi, and Icro Maremmani

Digital Object Identifier:
https://doi.org/10.62401/2531-4122-2024-43

Summary: Background Substance use disorders often co-occur in individuals with major depression. This post hoc analysis of the BRIDGE-II-MIX study aims to examine the clinical characterisation of subjects with major depression and alcohol/substance abuse in comorbidity, focusing on bipolarity features. Methods This multicenter, cross-sectional study included 2811 subjects with a major depressive episode. Sociodemographic and clinical data, as well as psychiatric comorbidity and treatment received, were collected and compared between major depressive patients with (SUD) and without (N-SUD) current alcohol/substance abuse. Results Of the total sample, 8.3% met the criteria for current alcohol/substance abuse. Bipolar disorder was diagnosed more frequently in the SUD group (41.9%) than in the N-SUD group (24.7%), as well as comorbidity with eating disorders, especially anorexia nervosa and bulimia nervosa (p<0.001), social phobia (p<0.001), and borderline personality disorder (p<0.001). In addition, SUD patients had more bipolar features than N-SUD patients, such as mixed features and early age at first depressive episode. SUD patients were also more likely than N-SUD patients to have (hypo)manic switches (p<0.001) and mood lability/irritability (p<0.001) in response to antidepressant treatment. Among current (hypo)manic symptoms, emotional/mood lability, grandiosity, and risky behaviour were most strongly associated with the presence of current alcohol/substance abuse. Conclusions The presence of substance use disorder should always be carefully considered in individuals with MDE, especially in the presence of bipolar features such as affective instability, manic/mixed symptoms, suicidality, early age of onset of depression, and comorbidity with eating disorders, social phobia, or borderline personality disorder. When treating individuals with MDE and comorbid substance abuse, the potential risk of mood destabilisation with antidepressant use should be considered.

Keywords: dual depression; substance abuse; major depressive episode; bipolar disorders.

 

EUROPAD - European Opiate Addiction Treatment Association
Brussels, Belgium, EU
P. IVA 01681650469 – Codice Fiscale 94002580465 Reserved Area
Tel/Phone: 0584 - 790073 - Email: info@heroinaddictionrelatedclinicalproblems.org
Start of page